This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,878.49, is for the delivery of GEMTESA 75 MG TABLET 90S and has a completion date of November 21, 2024.
The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.
The contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen is the prime contractor, and the contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.
Generated 2/27/25, 12:31 PM